JP2010510177A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510177A5
JP2010510177A5 JP2009536575A JP2009536575A JP2010510177A5 JP 2010510177 A5 JP2010510177 A5 JP 2010510177A5 JP 2009536575 A JP2009536575 A JP 2009536575A JP 2009536575 A JP2009536575 A JP 2009536575A JP 2010510177 A5 JP2010510177 A5 JP 2010510177A5
Authority
JP
Japan
Prior art keywords
group
substituted
independently
alkoxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009536575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510177A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2007/002096 external-priority patent/WO2008058402A1/en
Publication of JP2010510177A publication Critical patent/JP2010510177A/ja
Publication of JP2010510177A5 publication Critical patent/JP2010510177A5/ja
Pending legal-status Critical Current

Links

JP2009536575A 2006-11-17 2007-11-19 タンパク質フォールディング障害を治療するための化合物および方法 Pending JP2010510177A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85963206P 2006-11-17 2006-11-17
PCT/CA2007/002096 WO2008058402A1 (en) 2006-11-17 2007-11-19 Compounds and methods for treating protein folding disorders

Publications (2)

Publication Number Publication Date
JP2010510177A JP2010510177A (ja) 2010-04-02
JP2010510177A5 true JP2010510177A5 (https=) 2012-01-26

Family

ID=39401296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009536575A Pending JP2010510177A (ja) 2006-11-17 2007-11-19 タンパク質フォールディング障害を治療するための化合物および方法

Country Status (5)

Country Link
US (2) US8362066B2 (https=)
EP (1) EP2081892A4 (https=)
JP (1) JP2010510177A (https=)
CA (1) CA2668744C (https=)
WO (1) WO2008058402A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007138304A1 (en) 2006-05-30 2007-12-06 Astrazeneca Ab 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors
AR069340A1 (es) * 2007-11-26 2010-01-13 Merck & Co Inc Antagonistas del receptor de angiotensina ii
EP2234978B1 (en) 2007-12-20 2015-02-25 AstraZeneca AB Carbamoyl compounds as dgat1 inhibitors 190
BRPI1016109A2 (pt) 2009-06-19 2016-05-17 Astrazeneca Ab "composto, composição farmacêutica, e, processo para preparar um composto"
TW201107315A (en) 2009-07-27 2011-03-01 Kissei Pharmaceutical Indole derivatives, or the pharmaceutically acceptable salts
GB0918249D0 (en) 2009-10-19 2009-12-02 Respivert Ltd Compounds
US8299070B2 (en) 2009-11-25 2012-10-30 Japan Tobacco Inc. Indole compounds and pharmaceutical use thereof
UY33337A (es) 2010-10-18 2011-10-31 Respivert Ltd DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
EP2651405A2 (en) * 2010-12-14 2013-10-23 Electrophoretics Limited Casein kinase 1 (ck1 ) inhibitors
JO3350B1 (ar) 2011-03-07 2019-03-13 Merck Sharp & Dohme مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات
US20130072473A1 (en) * 2011-05-09 2013-03-21 Proteostasis Therapeutics, Inc. Compounds for treating protein folding disorders
NZ628072A (en) 2012-03-13 2015-08-28 Respivert Ltd Crystalline pi3 kinase inhibitors
TWI638802B (zh) 2012-05-24 2018-10-21 芬蘭商奧利安公司 兒茶酚o-甲基轉移酶活性抑制化合物
JO3279B1 (ar) 2013-03-15 2018-09-16 Respivert Ltd مشتقات 2-((4- امينو -3- (3- فلورو-5- هيدروكسي فينيل)-h1- بيرازولو [d-3,4] بيرمدين-1-يل )ميثيل )- 3- (2- تراي فلورو ميثيل ) بينزيل ) كوينازولين -4 (h3)- واحد واستخدامها كمثبطات فوسفواينوسيتايد 3- كاينيز
US9227977B2 (en) 2013-03-15 2016-01-05 Respivert Ltd. Phosphoinositide 3-kinase inhibitors
US10328040B2 (en) 2014-01-17 2019-06-25 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic methods
EA032374B1 (ru) * 2014-01-29 2019-05-31 ЮСиБи БАЙОФАРМА СПРЛ Гетероарильные амиды в качестве ингибиторов агрегации белков
WO2015130973A1 (en) * 2014-02-26 2015-09-03 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
CN104844471B (zh) * 2015-04-21 2017-05-03 苏州远智医药科技有限公司 一种作为dor受体拮抗剂的化合物
US11135186B2 (en) * 2015-12-29 2021-10-05 The Scripps Research Institute Regulators of the endoplasmic reticulum proteostasis network
CN105669516B (zh) * 2016-03-09 2018-08-03 中山大学 一种3,3’-双吲哚化合物的制备方法
US10231947B2 (en) 2017-01-23 2019-03-19 Arizona Board Of Regents On Behalf Of Arizona State University Isochroman compounds and methods of use thereof
US10238626B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US10238655B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Dihydroindene and tetrahydronaphthalene compounds
ES2974634T3 (es) 2018-12-21 2024-06-28 Celgene Corp Inhibidores de tienopiridinas de RIPK2
KR102472137B1 (ko) * 2020-09-22 2022-11-30 가톨릭대학교 산학협력단 Nlrp3 인플라마좀 억제제 및 이의 용도
FI4426434T3 (fi) 2021-11-02 2025-11-24 Flare Therapeutics Inc Pparg:n käänteisagonisteja ja niiden käyttöjä

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1282451B (de) * 1965-09-01 1968-11-07 Kalle Ag Lichtempfindliche Schicht und Verfahren zur Herstellung fixierter Bilder
JPS5113881A (en) * 1974-07-24 1976-02-03 Kanegafuchi Chemical Ind Enkabiniruno jugohoho
US4845079A (en) 1985-01-23 1989-07-04 Luly Jay R Peptidylaminodiols
US5066643A (en) 1985-02-19 1991-11-19 Sandoz Ltd. Fluorine and chlorine statine or statone containing peptides and method of use
US4894437A (en) 1985-11-15 1990-01-16 The Upjohn Company Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
US4885292A (en) 1986-02-03 1989-12-05 E. R. Squibb & Sons, Inc. N-heterocyclic alcohol renin inhibitors
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US4874867A (en) 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4870186A (en) 1987-05-22 1989-09-26 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4820843A (en) 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4980283A (en) 1987-10-01 1990-12-25 Merck & Co., Inc. Renin-inhibitory pepstatin phenyl derivatives
US5089471A (en) 1987-10-01 1992-02-18 G. D. Searle & Co. Peptidyl beta-aminoacyl aminodiol carbamates as anti-hypertensive agents
US5034512A (en) 1987-10-22 1991-07-23 Warner-Lambert Company Branched backbone renin inhibitors
US5063207A (en) 1987-10-26 1991-11-05 Warner-Lambert Company Renin inhibitors, method for using them, and compositions containing them
US5055466A (en) 1987-11-23 1991-10-08 E. R. Squibb & Sons, Inc. N-morpholino derivatives and their use as anti-hypertensive agents
US5036054A (en) 1988-02-11 1991-07-30 Warner-Lambert Company Renin inhibitors containing alpha-heteroatom amino acids
US5036053A (en) 1988-05-27 1991-07-30 Warner-Lambert Company Diol-containing renin inhibitors
DE3841520A1 (de) 1988-12-09 1990-06-13 Hoechst Ag Enzymhemmende harnstoffderivate von dipeptiden, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US5106835A (en) 1988-12-27 1992-04-21 American Cyanamid Company Renin inhibitors
US5063208A (en) 1989-07-26 1991-11-05 Abbott Laboratories Peptidyl aminodiol renin inhibitors
US5098924A (en) 1989-09-15 1992-03-24 E. R. Squibb & Sons, Inc. Diol sulfonamide and sulfinyl renin inhibitors
US5104869A (en) 1989-10-11 1992-04-14 American Cyanamid Company Renin inhibitors
US5114937A (en) 1989-11-28 1992-05-19 Warner-Lambert Company Renin inhibiting nonpeptides
US5095119A (en) 1990-03-08 1992-03-10 American Home Products Corporation Renin inhibitors
US5064965A (en) 1990-03-08 1991-11-12 American Home Products Corporation Renin inhibitors
US5075451A (en) 1990-03-08 1991-12-24 American Home Products Corporation Pyrrolimidazolones useful as renin inhibitors
US5039814A (en) 1990-05-02 1991-08-13 Merck & Co., Inc. Ortho-lithiation process for the synthesis of 2-substituted 1-(tetrazol-5-yl)benzenes
US5071837A (en) 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
US5130439A (en) 1991-11-18 1992-07-14 Lo Young S Tetrazolylphenylboronic acid intermediates for the synthesis of AII receptor antagonists
US5206374A (en) 1991-11-18 1993-04-27 E. I. Du Pont De Nemours And Company Process for preparing tetrazolylphenylboronic acid intermediates
US5310928A (en) 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
FR2688501B1 (fr) * 1992-03-13 1995-06-23 Oreal Compositions de teinture des fibres keratiniques a base de monoindolyl 1,4-naphtoquinones ou leurs leucoderives, nouveaux composes monoindolyl 1,4-naphtoquinones et leurs leucoderives.
US6489355B2 (en) * 1993-12-01 2002-12-03 Eli Lilly And Company Methods of inhibiting the effects of amyloidogenic proteins
DE69711068T2 (de) 1996-10-29 2002-09-12 MERCK & CO., INC. Verfahren zur kristallisation von losartan
JPH11228570A (ja) * 1998-02-20 1999-08-24 Taisho Pharmaceut Co Ltd 5−(置換フェニル)−4−(3−インドリル)イミダゾール誘導体
CA2496859A1 (en) * 1998-05-04 1999-11-11 Zentaris Gmbh Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
US6399780B1 (en) * 1999-08-20 2002-06-04 Cephalon, Inc. Isomeric fused pyrrolocarbazoles and isoindolones
CA2357450A1 (en) * 2000-09-29 2002-03-29 Warner-Lambert Company Phenoxazine analogs useful as amyloid aggregation inhibitors and treatment of alzheimer's disease and disorders related to amyloidosis
GB0130305D0 (en) * 2001-12-19 2002-02-06 Amersham Plc Compounds for imaging alzheimers disease
EP1472245A2 (en) * 2002-02-06 2004-11-03 Vertex Pharmaceuticals Incorporated Heteroaryl compounds useful as inhibitors of gsk-3
IL164082A0 (en) * 2002-03-28 2005-12-18 Eisai Co Ltd Azaindole derivatives and pharmaceutical compositions containing the same
JP2004250411A (ja) * 2003-02-21 2004-09-09 Bf Kenkyusho:Kk アミロイドβ蓄積性疾患の診断プローブおよび治療用化合物
CN1271068C (zh) * 2003-03-25 2006-08-23 上海医药工业研究院 一种奥美沙坦酯的制备方法
WO2004100998A2 (en) * 2003-05-07 2004-11-25 General Electric Company Compositions and methods for non-invasive imaging of soluble beta-amyloid
PL1653950T3 (pl) 2003-07-31 2008-08-29 Nicox Sa Pochodne nitrooksylowe losartanu, walsartanu, kandesartanu, telmisartanu, eprosartanu i olmesartanu jako antagonisty receptorów angiotensyny II do leczenia chorób sercowo-naczyniowych
CA2536975A1 (en) 2003-08-28 2005-03-17 Nitromed, Inc. Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
US7265245B2 (en) * 2003-10-08 2007-09-04 Innovaprotean, S.L Compounds useful for the treatment of diseases associated with the formation of amyloid fibrils
EP1711454A4 (en) 2004-01-27 2007-04-04 Merck Frosst Company COMBINATION THERAPY FOR TREATING DISEASES OR CONDITIONS INDUCED BY CYCLOOXYGENASE-2 IN PATIENTS WITH RISK OF THROMBOTIC CARDIOVASCULAR EVENTS
US8710088B2 (en) * 2004-02-11 2014-04-29 Max-Delbruck-Centrum Fur Molekulare Medizin Pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
US20060142591A1 (en) * 2004-10-25 2006-06-29 Susan Lindquist DAPH analogs and inhibition of protein aggregation
EP1893576A4 (en) * 2005-05-27 2010-03-17 Univ Kingston TREATMENT OF PROTEIN DISORDERING
WO2007047204A1 (en) * 2005-10-11 2007-04-26 University Of Pittsburgh Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins
JP2010504326A (ja) * 2006-09-21 2010-02-12 ワイス エルエルシー β−セクレターゼを阻害するためのインドリルアルキルピリジン−2−アミン

Similar Documents

Publication Publication Date Title
JP2010510177A5 (https=)
JP2009263394A5 (https=)
JP2008505194A5 (https=)
WO2008087611A3 (en) Pyrrolidine- and piperidine- bis-amide derivatives
JP2019104748A5 (https=)
JP2012506896A5 (https=)
JP2020502049A5 (https=)
JP2010527913A5 (https=)
JP2013521312A5 (https=)
JP2018135343A5 (https=)
JP2011137006A5 (https=)
JP2011522789A5 (https=)
JP2016520618A5 (https=)
JP2009161540A5 (https=)
JP2009076835A5 (https=)
NO20080738L (no) Fremgangsmater for neurobeskyttelse
JP2011006405A5 (ja) 化合物
JP2016510323A5 (https=)
JP2011037870A5 (https=)
JP2013507434A5 (https=)
JP2010501478A5 (https=)
JP2010155827A5 (https=)
JP2010504286A5 (https=)
NZ605690A (en) Oxadiazole inhibitors of leukotriene production
JP2009539943A5 (https=)